Newsroom
July 31, 2024
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a potential treatment for Alzheimer’s disease. Almost half of what makes up the human genome are […]
July 5, 2024
Written by Claire Kowalick A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. The scientists […]
May 9, 2024
We all know that exercise is good for us, but figuring out the “why” and “how” of physical exercise’s effect on the body is the goal of a 10-year, multi-million dollar project through the National Institutes of Health called the Molecular Transducers of Physical Activity Consortium, (MoTrPAC).
January 25, 2024
It is a far cry from the traditionally thought-of “vegetative state” in which the mind is absent while the body lives on. Indeed, it is the opposite. Children with “locked-in syndrome,” unable to move or speak, are awake and fully aware of their surroundings.
January 22, 2024
A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio reported.
December 27, 2023
Ching-Kang Jason Chen, PhD, from The University of Texas Health Science Center at San Antonio, was recently awarded a $500,000 UT System Faculty Science and Technology Acquisition and Retention (STARs) award by the UT System Board of Regents.
